709648-80-6 Usage
Uses
Used in Pharmaceutical Industry:
METHYL4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHENE-2-CARBOXYLATE is used as a reagent for the synthesis of new drugs with therapeutic properties, leveraging its unique chemical structure to contribute to the development of novel medicinal compounds.
Used in Materials Science:
In the field of materials science, METHYL4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHENE-2-CARBOXYLATE is used as a precursor for the production of organic electronic devices and optoelectronic materials, taking advantage of its chemical properties to enhance the performance of these devices.
Used in Organic Light-Emitting Diodes (OLEDs):
METHYL4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHENE-2-CARBOXYLATE is used as a component in the development of OLEDs, where its properties contribute to the creation of efficient and high-quality light-emitting materials.
Used in Organic Photovoltaic Devices:
In the realm of organic photovoltaics, METHYL4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHENE-2-CARBOXYLATE is used as a material in the fabrication of solar cells, potentially improving the efficiency and performance of these renewable energy technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 709648-80-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,9,6,4 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 709648-80:
(8*7)+(7*0)+(6*9)+(5*6)+(4*4)+(3*8)+(2*8)+(1*0)=196
196 % 10 = 6
So 709648-80-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H17BO4S/c1-11(2)12(3,4)17-13(16-11)8-6-9(18-7-8)10(14)15-5/h6-7H,1-5H3
709648-80-6Relevant academic research and scientific papers
NOVEL HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
-
Page/Page column 53-54; 70-71, (2022/01/24)
Provided are heterocyclic compounds of formula (I) as bromodomain and extraterminal (BET) inhibitors, pharmaceutical compositions comprising the compounds, their synthesis and their use for treating diseases and conditions wherein inhibition of one or more BET bromodomains provides a benefit.
BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS
-
Page/Page column 39, (2010/01/30)
The present invention provides Gyrase B and/or Topoisomerase IV par E inhibitors, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonas spp., Acenetobacter spp., Moraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Ktycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Coryne bacterium, Bacillus spp., Enterobactericeae,' (E.coli, Klebsiella spp., Proteus spp.,etc. ) or any combination thereof Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections. (Formula)
TREATMENT OF ALZHEIMER'S DISEASE AND RELATED CONDITIONS
-
Page/Page column 18, (2010/11/28)
Compounds of formula (I) inhibit microtubule affinity regulating kinase (MARK), and hence are suitable for treating diseases associated with abnormal phosphorylation of tau.
